B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33735607.
- Also identified by DOI 10.1016/j.cell.2021.02.015 and PMC identifier 9196326.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The long non-coding RNA (lncRNA) XIST establishes X chromosome inactivation (XCI) in female cells in early development and thereafter is thought to be largely dispensable. Here, we show XIST is continually required in adult human B cells to silence a subset of X-linked immune genes such as TLR7. XIST-dependent genes lack promoter DNA methylation and require continual XIST-dependent histone deacetylation. XIST RNA-directed proteomics and CRISPRi screen reveal distinctive somatic cell-type-specific XIST complexes and identify TRIM28 that mediates Pol II pausing at promoters of X-linked genes in B cells. Single-cell transcriptome data of female patients with either systemic lupus erythematosus or COVID-19 infection revealed XIST dysregulation, reflected by escape of XIST-dependent genes, in CD11c<sup>+</sup> atypical memory B cells (ABCs). XIST inactivation with TLR7 agonism suffices to promote isotype-switched ABCs. These results indicate cell-type-specific diversification and function for lncRNA-protein complexes and suggest expanded roles for XIST in sex-differences in biology and medicine.
Medical subject headings
- B-Lymphocytes
- COVID-19
- Lupus Erythematosus, Systemic
- RNA, Long Noncoding
- Toll-Like Receptor 7
- X Chromosome Inactivation